Literature DB >> 2295798

The use of transfected fibroblasts and transgenic mice establishes that stimulation of T cells by the Mycoplasma arthritidis mitogen is mediated by E alpha.

B C Cole1, C S David, D H Lynch, D R Kartchner.   

Abstract

Mycoplasma arthritidis produces a soluble protein which is active for murine and human lymphocytes when presented by Ia-bearing accessory cells. By using fibroblasts transfected in vitro with various class II Ag, we demonstrated that presentation of the M. arthritidis mitogen (MAM) to T cells was mediated by E alpha-containing molecules. We also showed that splenocytes from transgenic mice expressing E alpha heterozygously (B10.TRG E alpha+) or homozygously (B10.E alpha TG +/+) underwent a similar proliferation in response to MAM as compared with the failure of control B10.TRG E alpha- splenocytes to respond to MAM. Although splenocytes from inbred C3H and CBA mice exhibited much higher proliferative responses to MAM than did those from B10.TRG.E alpha+ or B10.E alpha TG +/+ mice, flow cytometry showed similar levels of E alpha expression. Furthermore, gamma-irradiated splenocytes from B10.TRG E alpha + mice presented MAM to T hybridoma cells with a similar efficacy as did splenocytes from C3H mice. The lesser response to MAM of lymphocytes from the E alpha transgenic mice as compared with those from C3H and B10.K mice was likewise not due to differential expression of their V beta TCR. We conclude that presentation of MAM to T cells is accomplished by E alpha-containing molecules. The studies also suggest that the conserved, nonpolymorphic regions of class II molecules may play an important role in host immune response to microbial products.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295798

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM.

Authors:  B C Cole; A D Sawitzke; E A Ahmed; C L Atkin; C S David
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Functional analysis of Mycoplasma arthritidis-derived mitogen interactions with class II molecules.

Authors:  C Bernatchez; R Al-Daccak; P E Mayer; K Mehindate; L Rink; S Mecheri; W Mourad
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  The minimal polymorphism of class II E alpha chains is not due to the functional neutrality of mutations.

Authors:  Z T Chu; C Carswell-Crumpton; B C Cole; P P Jones
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

4.  Mycoplasma arthritidis mitogen up-regulates human NK cell activity.

Authors:  J A D'Orazio; B C Cole; J Stein-Streilein
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

5.  Modulation of cytokine profiles by the Mycoplasma superantigen Mycoplasma arthritidis mitogen parallels susceptibility to arthritis induced by M. arthritidis.

Authors:  H H Mu; A D Sawitzke; B C Cole
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Expression of the superantigen Mycoplasma arthritidis mitogen in Escherichia coli and characterization of the recombinant protein.

Authors:  K L Knudtson; M Manohar; D E Joyner; E A Ahmed; B C Cole
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line.

Authors:  R al-Daccak; K Mehindate; J Hébert; L Rink; S Mecheri; W Mourad
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  Replacement of the DR alpha chain with the E alpha chain enhances presentation of Mycoplasma arthritidis superantigen by the human class II DR molecule.

Authors:  T Sawada; R Pergolizzi; K Ito; J Silver; C Atkin; B C Cole; M D Chang
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Association of Mycoplasma arthritidis mitogen with lethal toxicity but not with arthritis in mice.

Authors:  Wenyi Luo; Huilan Yu; Zuhua Cao; Trenton R Schoeb; Michele Marron; Kevin Dybvig
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441

10.  Superantigen-presentation by rat major histocompatibility complex class II molecules RT1.Bl and RT1.Dl.

Authors:  Henry Dlaske; Hatice Karaüzüm; Elisa Monzon-Casanova; Ronald Rudolf; Lisa Starick; Ingrid Müller; Gerhild Wildner; Maria Diedrichs-Möhring; Norbert Koch; Tohru Miyoshi-Akiyama; Takehiko Uchiyama; Kurt Wonigeit; Bernhard Fleischer; Silke Overbeck; Lothar Rink; Thomas Herrmann
Journal:  Immunology       Date:  2008-12-24       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.